Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer

Clinical trial NCT02229149 · TERMINATED

Trial details

NCT number: NCT02229149
Sponsor: US Oncology Research
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms Malignant Tumor of the Breast

Start date: 2014-12-01
Primary completion: 2022-01-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.